Special treatment issues: maintaining and discontinuing psychotropic medications.
Suppes
T
T
Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, USA.
Baldessarini
R J
RJ
Motohashi
N
N
Tondo
L
L
Viguera
A C
AC
D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000145:classification; D001714:Bipolar Disorder / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy*; D003866:Depressive Disorder / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000009:adverse effects* / Q000145:classification; D012008:Recurrence; D012307:Risk Factors; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000523:psychology
D000928:Antidepressive Agents; D011619:Psychotropic Drugs